Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis
Main Authors: | van den Broek, Alexandra J., Schmidt, Marjanka K., van ‘t Veer, Laura J., Tollenaar, Rob A. E. M., van Leeuwen, Flora E. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376645/ |
Similar Items
-
Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population
by: van den Broek, Alexandra J, et al.
Published: (2015) -
Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
by: Schmidt, MK, et al.
Published: (2005) -
HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
by: van der Groep, Petra, et al.
Published: (2013) -
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
by: Iqbal, J, et al.
Published: (2012) -
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis
by: Phi, Xuan-Anh, et al.
Published: (2016)